Insertion-and-deletion-derived tumour-specific neoantigens and the immunogenic phenotype: a pan-cancer analysis-Reference-Cited by-同舟云学术

Insertion-and-deletion-derived tumour-specific neoantigens and the immunogenic phenotype: a pan-cancer analysis

Published:2017-08 Issue:8 Volume:18 Page:1009-1021
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Turajlic Samra,Litchfield Kevin,Xu Hang,Rosenthal Rachel,McGranahan Nicholas,Reading James L,Wong Yien Ning S,Rowan Andrew,Kanu Nnennaya,Al Bakir Maise,Chambers Tim,Salgado Roberto,Savas Peter,Loi Sherene,Birkbak Nicolai J,Sansregret Laurent,Gore Martin,Larkin James,Quezada Sergio A,Swanton Charles

Publisher

Elsevier BV

Reference72 articles.

1. Tumor neoantigens: building a framework for personalized cancer immunotherapy;Gubin;J Clin Invest,2015

2. The Cancer Genome Atlas Pan-Cancer analysis project;Weinstein;Nat Genet,2013

3. Important role of indels in somatic mutations of human cancer genes;Yang;BMC Med Genet,2010

4. ‘Final common pathway’ of human cancer immunotherapy: targeting random somatic mutations;Tran;Nat Immunol,2017

5. Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens;Gubin;Nature,2014

Cited by 811 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Induction of a mismatch repair deficient genotype by tailored chemical mutagenesis in experimental models of cancer;Cancer Cell;2025-07

2. Succinate dehydrogenase expression and activity: A potential molecular fingerprint with metabolism-rewiring properties and clinical impact in undifferentiated pleomorphic sarcomas;2025-06-23

3. Advances and challenges in neoantigen prediction for cancer immunotherapy;Frontiers in Immunology;2025-06-12

4. Neoantigen-Based Immunotherapy in Lung Cancer: Advances, Challenges and Prospects;Cancers;2025-06-12

5. Explosive tumor growth in a patient with colon cancer is associated with reduced neoantigen levels and decreased interferon-gamma (IFN-γ) signaling;BMC Cancer;2025-06-05